Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P van Meerbeeck

Showing results (121-130 of 250) with videos related to

Pageof 25
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-AnalysisJanah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1989
Respiratory insufficiency in acid maltase deficiency: the effect of high protein dietH E Demey, J P Van Meerbeeck, M F Vandewoude, et al.
Respiratory Medicine|September 1, 1996
Evidence for marked eosinophil degranulation in a case of eosinophilic pneumoniaP G Jorens, F J Van Overveld, J P Van Meerbeeck, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibodyJo Raskin, Pegah Masrori, Antonin Cant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study GroupM Salden, T A Splinter, H A Peters, et al.
Expert Opinion on Investigational Drugs|June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancerChristian Rolfo, Luis E Raez, Giuseppe Bronte, et al.
Insights Into Imaging|November 17, 2017
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphologyAnnemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancers|August 12, 2023
Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsKurt G Tournoy, Valerie Adam, Inge Muylle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?Gijsbert W P M Kramer, Steven Gans, Eric Ullmann, et al.
Pageof 25

Showing results (121-130 of 250) with videos related to

Sort By:
Pageof 25
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 3, 2021
DNA Methylation as a Diagnostic Biomarker for Malignant Mesothelioma: A Systematic Review and Meta-AnalysisJanah Vandenhoeck, Jan P van Meerbeeck, Erik Fransen, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|May 1, 1989
Respiratory insufficiency in acid maltase deficiency: the effect of high protein dietH E Demey, J P Van Meerbeeck, M F Vandewoude, et al.
Respiratory Medicine|September 1, 1996
Evidence for marked eosinophil degranulation in a case of eosinophilic pneumoniaP G Jorens, F J Van Overveld, J P Van Meerbeeck, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Recurrent dysphasia due to nivolumab-induced encephalopathy with presence of Hu autoantibodyJo Raskin, Pegah Masrori, Antonin Cant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2000
The urokinase-type plasminogen activator system in resected non-small-cell lung cancer. Rotterdam Oncology Thoracic Study GroupM Salden, T A Splinter, H A Peters, et al.
Expert Opinion on Investigational Drugs|June 25, 2013
BIBF 1120/ nintedanib : a new triple angiokinase inhibitor-directed therapy in patients with non-small cell lung cancerChristian Rolfo, Luis E Raez, Giuseppe Bronte, et al.
Insights Into Imaging|November 17, 2017
Evaluation of the solitary pulmonary nodule: size matters, but do not ignore the power of morphologyAnnemie Snoeckx, Pieter Reyntiens, Damien Desbuquoit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancers|August 12, 2023
Health Outcomes with Curative and Palliative Therapies in Real World: Role of the Quality of Life Summary Score in Thoracic Oncology PatientsKurt G Tournoy, Valerie Adam, Inge Muylle, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Hypofractionated external beam radiotherapy as retreatment for symptomatic non-small-cell lung carcinoma: an effective treatment?Gijsbert W P M Kramer, Steven Gans, Eric Ullmann, et al.
Pageof 25